Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Molecular Neuroscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02736730PMID 7654518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors.

  1994influential reference
• Pan-neuronal expression of chromogranin A in rat nervous system.

  1994cited by this paper
• Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules

  1994cited by this paper
• Expression and regulation of the bovine vesicular monoamine transporter gene

  1993cited by this paper
• Functional Identification and Molecular Cloning of a Human Brain Vesicle Monoamine Transporter

  1993cited by this paper
• Vesicle monoamine transporters 1 and 2: differential distribution and regulation of their mRNAs in chromaffin and ganglion cells of rat adrenal medulla.

  1993cited by this paper
• A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter.

  1992cited by this paper
• Expression cloning of a reserpine-sensitive vesicular monoamine transporter.

  1992cited by this paper
• Comparison of histamine and 5-hydroxytryptamine content and secretion in rat mast cells isolated from different anatomical locations.

  1989cited by this paper
• Neuropeptide tyrosine in the rat adrenal gland--immunohistochemical and in situ hybridization studies.

  1988cited by this paper
• Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

  1986cited by this paper
• Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus.

  1985cited by this paper
• Environmental influences in the development of neural crest derivatives: glucocorticoids, growth factors, and chromaffin cell plasticity

  1985cited by this paper
• Isolation of histamine-containing cells from rat gastric mucosa: biochemical and morphologic differences from mast cells.

  1981cited by this paper
• Isolation of histamine-containing cells from rat gastric mucosa: Biochemical and morphologic differences from mast cells

  1981cited by this paper

• Redefining dopaminergic synapses beyond the classical paradigm.

  2025cites this paper
• Structural insights into substrate transport and drug inhibition of the human vesicular monoamine transporter 2 (VMAT2)

  2025cites this paper
• Drug inhibition and substrate transport mechanisms of human VMAT2

  2025cites this paper
• Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs.

  2025cites this paper
• Peripheral Catecholamine Systems: An Evolutionary Perspective.

  2025cites this paper
• Synaptic vesicle characterization of iPSC-derived dopaminergic neurons provides insight into distinct secretory vesicle pools

  2024cites this paper
• Beyond the Brain: Perinatal Exposure of Rats to Serotonin Enhancers Induces Long-Term Changes in the Jejunum and Liver

  2024cites this paper
• Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines

  2024cites this paper
• Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta

  2024cites this paper
• Cell-type and dynamic state govern genetic regulation of gene expression in heterogeneous differentiating cultures

  2024cites this paper
• Fluoxetine reverses early-life stress-induced depressive-like behaviors and region-specific alterations of monoamine transporters in female mice.

  2024cites this paper
• Structural mechanisms for VMAT2 inhibition by tetrabenazine

  2024cites this paper
• Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta

  2024cites this paper
• Cell type and dynamic state govern genetic regulation of gene expression in heterogeneous differentiating cultures

  2024cites this paper
• Transport and inhibition mechanism for VMAT2-mediated synaptic loading of monoamines

  2023cites this paper
• Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2

  2023cites this paper
• Transport and inhibition mechanisms of human VMAT2

  2023cites this paper
• Behavioral and Transcriptomic Changes Following Brain-Specific Loss of Noradrenergic Transmission

  2023cites this paper
• Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions

  2023cites this paper
• Structural mechanisms for VMAT2 inhibition by tetrabenazine

  2023cites this paper
• Differential Expression of Secretogranins II and III in Canine Adrenal Chromaffin Cells and Pheochromocytomas

  2022cites this paper
• SNX5 targets a monoamine transporter to the TGN for assembly into dense core vesicles by AP-3

  2022cites this paper
• Special Section on New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters — Minireview Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta -Iodobenzylguanidine

  2022cites this paper
• Rnf220 is Implicated in the Dorsoventral Patterning of the Hindbrain Neural Tube in Mice

  2022cites this paper
• Clinical Applications and the Roles of Transporters in Disposition, Tumor Targeting, and Tissue Toxicity of meta-Iodobenzylguanidine

  2022cites this paper
• Vortioxetine attenuates the effects of early-life stress on depression-like behaviors and monoamine transporters in female mice.

  2021cites this paper
• Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.

  2021cites this paper
• An investigation into the antidyskinetic and reinforcing effects of UWA-101 in Sprague Dawley rats

  2020cites this paper
• Adrenergic chromaffin cells are adrenergic even in the absence of epinephrine

  2020cites this paper
• Localization, proteomics, and metabolite profiling reveal a putative vesicular transporter for UDP-glucose

  2020cites this paper
• Differences in the expression of catecholamine-synthesizing enzymes between vesicular monoamine transporter 1- and 2-immunoreactive glomus cells in the rat carotid body.

  2020cites this paper
• Tetrabenazine Facilitates Exocytosis by Enhancing Calcium-Induced Calcium Release through Ryanodine Receptors

  2019influential citation
• Monoamine Transmitters

  2019cites this paper
• Presynaptic regulation of dopamine release: Role of the DAT and VMAT2 transporters

  2019cites this paper
• Chromaffin Cells of the Adrenal Medulla: Physiology, Pharmacology, and Disease.

  2019cites this paper
• Differential sorting behavior for soluble and transmembrane cargoes at the trans-Golgi network in endocrine cells

  2019cites this paper
• Perivascular Adipocytes Store Norepinephrine by Vesicular Transport

  2019cites this paper
• Interaction of neurotransmitters and neurochemicals with lymphocytes.

  2019cites this paper
• Targeting Type 1 Diabetes: Selective Approaches for New Therapies.

  2019cites this paper
• Embracing diversity in the 5-HT neuronal system

  2019cites this paper
• Transcriptomic and neurochemical analysis of the stellate ganglia in mice highlights sex differences

  2018cites this paper
• Mediators of Inflammation

  2018cites this paper
• Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.

  2018cites this paper
• Immunochemical localization of vesicular monoamine transporter 2 (VMAT2) in mouse brain.

  2017influential citation
• Current Status, Gaps, and Weaknesses of the Mechanism of Selective Dopaminergic Toxicity of MPTP/MPP+

  2017cites this paper
• Kirsi Mikkola VMAT 2 AND GLP-1 R TARGETING TRACERS FOR PANCREATIC BETA CELL IMAGING

  2017cites this paper
• Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.

  2016cites this paper
• Enteric Neuronal Regulation of Intestinal Inflammation.

  2016cites this paper
• Nanoparticles for Pancreatic Islet Imaging

  2016cites this paper
• Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.

  2016cites this paper
• The role of serotonin and its receptors in activation of immune responses and inflammation

  2015cites this paper
• Modulation of the expression and function of dopaminergic presynaptic proteins by the statins : Potential implication for the therapeutic intervention in Parkinson’s disease.

  2015cites this paper
• Chemical coding and chemosensory properties of cholinergic brush cells in the mouse gastrointestinal and biliary tract

  2015cites this paper
• A study of possible environmental modulators of neostriatal dopaminergic synapses, with focus on dietary fat and polychlorinated biphenyl 153

  2015cites this paper
• Vesicular Amine Transporter VMAT2 in the Rat Ileum: from Principal Mechanism to Clinical Applications

  2015cites this paper
• Serotonergic Modulation of the Olfactory Bulb

  2015cites this paper
• The Role of E3 Ligase Parkin in Trafficking of Monoamine Storage Vesicles in Rat Model of Methamphetamine Neurotoxicity

  2015cites this paper
• Presynaptic effects of levodopa and their possible role in dyskinesia

  2015cites this paper
• Differential regulation of catecholamine synthesis and transport in rat adrenal medulla by fluoxetine treatment.

  2015cites this paper
• Overview: Presynaptic Terminal Proteins Orchestrate Stepwise Synaptic Vesicle Phases

  2015cites this paper
• Design, synthesis, and pharmacological evaluation of three series of lobelane analogs as inhibitors of the vesicular monoamine transporter (VMAT2)

  2015cites this paper
• Teemu Kalliokoski FUNCTIONAL IMAGING OF INSULITIS IN TYPE 1 DIABETES

  2014cites this paper
• Origins of the sympathetic innervation to the nasal-associated lymphoid tissue (NALT): an anatomical substrate for a neuroimmune connection.

  2014influential citation
• New Model for Gastroenteropancreatic Large-Cell Neuroendocrine Carcinoma: Establishment of Two Clinically Relevant Cell Lines

  2014cites this paper
• Segregation of neuronal and neuroendocrine differentiation in the sympathoadrenal lineage

  2014cites this paper
• New perspectives of vesicular monoamine transporter 2 chemical characteristics in mammals and its constant expression in type 1 diabetes rat models.

  2014cites this paper
• The vesicular monoamine transporter 2: an underexplored pharmacological target.

  2014cites this paper
• The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse.

  2014cites this paper
• Translation, Touch, and Overlap in Multi-fluorescence Confocal Laser Scanning Microscopy to Quantitate Synaptic Connectivity

  2014cites this paper
• Functional Imaging of Insulitis in Type 1 Diabetes

  2014cites this paper
• Regulation of DA Homeostasis and Role of VMAT2 in DA-Induced Neurodegeneration

  2014cites this paper
• Exclusive expression of VMAT2 in noradrenergic neurons increases viability of homozygous VMAT2 knockout mice.

  2013cites this paper
• Localization and expression of VMAT2 aross mammalian species: a translational guide for its visualization and targeting in health and disease.

  2013cites this paper
• DIET-INDUCED OBESITY: DOPAMINERGIC AND BEHAVIORAL MECHANISMS AS OUTCOMES AND PREDICTORS

  2013cites this paper
• Molecular Imaging Methods in Diabetes-Related Studies

  2013cites this paper
• Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models

  2013cites this paper
• Serotonin circuits and anxiety: what can invertebrates teach us?

  2012cites this paper
• Imaging the islet graft by positron emission tomography

  2012cites this paper
• In Vivo Imaging of Endogenous Pancreatic β-Cell Mass in Healthy and Type 1 Diabetic Subjects Using 18F-Fluoropropyl-Dihydrotetrabenazine and PET

  2012cites this paper
• Gastroenteropancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1

  2012cites this paper
• Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.

  2012cites this paper
• Imagerie multiphotonique de la sérotonine par contraste endogène : vers un outil pour évaluer la concentration de la sérotonine in vivo

  2012cites this paper
• Efferent projections of C3 adrenergic neurons in the rat central nervous system

  2012cites this paper
• Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor

  2012cites this paper
• Mechanisms of dopamine quantal size regulation.

  2012cites this paper
• Vesicular and plasma membrane transporters for neurotransmitters.

  2012cites this paper
• [Breast implant scandal shows weaknesses in the European information practice].

  2012cites this paper
• L'activation de la voie du GMP cyclique réduit le comportement d'auto-administration de cocaïne chez le rat : implication de régulations épigénétiques

  2012influential citation
• Caractérisations biochimique anatomique et comportementale des souris dépourvues de la protéines STOP : un modèle expérimental pour l'étude de symptômes psycho-affectifs

  2011cites this paper
• Pancreatic Beta Cell Mass PET Imaging and Quantification with [11C]DTBZ and [18F]FP-(+)-DTBZ in Rodent Models of Diabetes

  2011cites this paper
• PRECLINICAL EVALUATION OF LOBELINE FOR THE TREATMENT OF ADHD: COMPARISON WITH PSYCHOSTIMULANT THERAPIES

  2011influential citation
• Vesicular monoamine transporter-1 (VMAT-1) mRNA and immunoreactive proteins in mouse brain.

  2011cites this paper
• Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders

  2011cites this paper
• VMAT2: a dynamic regulator of brain monoaminergic neuronal function interacting with drugs of abuse

  2011cites this paper
• [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].

  2011cites this paper
• Vesicular monoamine transporters: Structure‐function, pharmacology, and medicinal chemistry

  2011cites this paper
• Design, synthesis and interaction at the vesicular monoamine transporter-2 of lobeline analogs: potential pharmacotherapies for the treatment of psychostimulant abuse.

  2011cites this paper
• Glutamatergic neurotransmission in the synapsin I and II double knock-out mouse.

  2011cites this paper
• [Serotonin now: Part 1. Neurobiology and developmental genetics].

  2010cites this paper
• Identification of new pancreatic beta cell targets for in vivo imaging by a systems biology approach.

  2010cites this paper